(MedPage Today) -- The U.S. Department of Justice has charged a former vice president and lawyer at GlaxoSmithKline with trying to cover up evidence that the company was illegally marketing the depression drug bupropion (Wellbutrin) as a weight-loss aid. Read from Source
